hazards regression models were used to estimate the relative risk (RR) and 95% CI for associations between phosphatidylcholine and T2D while accounting for potential confounders, including age, BMI, lifestyle factors, family history of diabetes, and present chronic conditions (full list of covariates is available in Fig. 1 ).
We documented 7,063, 4,465, and 3,531 cases of T2D during the follow-ups of NHS , NHS II (1991-2011), and HPFS (1986-2010), respectively. Compared with people in the lowest quintiles of dietary phosphatidylcholine intakes, the multivariate-adjusted RR of T2D for those in the highest quintiles was 1.36 (95% CI 1.26-1.48) in NHS, 1.35 (95% CI 1.22-1.50) in NHS II, 1.28 (95% CI 1.14-1.44) in HPFS, and 1.34 (95% CI 1.27-1.42) in the pooled analysis. The association was 1.24 (95% CI 1.16-1.33) after further adjustment for the three major food sources (red meat, eggs, and seafoods) and 1.27 (95% CI 1.20-1.39) with all choline-containing components and betaine mutually adjusted.
With an increase of 100 mg choline from phosphatidylcholine, the risk of T2D increased by 17% (95% CI 13-22). We did not observe significant interaction between phosphatidylcholine and age, BMI, or major dietary sources of phosphatidylcholine (P . 0.07 for all); the association was consistent in the subgroups (Fig. 1) .
Given the observational nature, our study alone could not prove causality. Similar to other observational studies, it was difficult to rule out residual confounding, even though we carefully controlled for the potential confounders in the analyses. In addition, measurement errors were inevitable in the estimates of food and nutrient intakes. Adjustment for energy intake and use of cumulatively average intake levels might reduce the magnitude of measurement errors to some extent.
In summary, for the first time our study associated dietary intakes of phosphatidylcholine with incident T2D risk in multiple prospective cohorts with a large sample size, high rates of long-term follow-up, and detailed and repeated assessments of diet and lifestyle. Our findings lend support to dietary intervention strategies targeting dietary sources of gut microbiota metabolites in prevention of T2D. are the guarantors of this work and, as such, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Prior Presentation. Parts of this study were presented at Experimental Biology 2014, San Diego, CA, 26230 April 2014.
